112 related articles for article (PubMed ID: 16467259)
1. Foxa1 and Foxa2 interact with the androgen receptor to regulate prostate and epididymal genes differentially.
Yu X; Gupta A; Wang Y; Suzuki K; Mirosevich J; Orgebin-Crist MC; Matusik RJ
Ann N Y Acad Sci; 2005 Dec; 1061():77-93. PubMed ID: 16467259
[TBL] [Abstract][Full Text] [Related]
2. Identification of DNA-dependent protein kinase as a cofactor for the forkhead transcription factor FoxA2.
Nock A; Ascano JM; Jones T; Barrero MJ; Sugiyama N; Tomita M; Ishihama Y; Malik S
J Biol Chem; 2009 Jul; 284(30):19915-26. PubMed ID: 19478084
[TBL] [Abstract][Full Text] [Related]
3. EP300/CREBBP acetyltransferase inhibition limits steroid receptor and FOXA1 signaling in prostate cancer cells.
Huttunen J; Aaltonen N; Helminen L; Rilla K; Paakinaho V
Cell Mol Life Sci; 2024 Apr; 81(1):160. PubMed ID: 38564048
[TBL] [Abstract][Full Text] [Related]
4. Stable chromatin binding prevents FoxA acetylation, preserving FoxA chromatin remodeling.
Kohler S; Cirillo LA
J Biol Chem; 2010 Jan; 285(1):464-72. PubMed ID: 19897491
[TBL] [Abstract][Full Text] [Related]
5. Changes at the nuclear lamina alter binding of pioneer factor Foxa2 in aged liver.
Whitton H; Singh LN; Patrick MA; Price AJ; Osorio FG; López-Otín C; Bochkis IM
Aging Cell; 2018 Jun; 17(3):e12742. PubMed ID: 29484800
[TBL] [Abstract][Full Text] [Related]
6. Rarγ -Foxa1 signaling promotes luminal identity in prostate progenitors and is disrupted in prostate cancer.
Felice D; Alaimo A; Bressan D; Genovesi S; Marmocchi E; Annesi N; Beccaceci G; Dalfovo D; Cutrupi F; Foletto V; Lorenzoni M; Gandolfi F; Kannan S; Verma CS; Vasciaveo A; Shen MM; Romanel A; Chiacchiera F; Cambuli F; Lunardi A
bioRxiv; 2024 Mar; ():. PubMed ID: 38496627
[TBL] [Abstract][Full Text] [Related]
7. Dual role of FoxA1 in androgen receptor binding to chromatin, androgen signalling and prostate cancer.
Sahu B; Laakso M; Ovaska K; Mirtti T; Lundin J; Rannikko A; Sankila A; Turunen JP; Lundin M; Konsti J; Vesterinen T; Nordling S; Kallioniemi O; Hautaniemi S; Jänne OA
EMBO J; 2011 Sep; 30(19):3962-76. PubMed ID: 21915096
[TBL] [Abstract][Full Text] [Related]
8. Androgen receptor-independent function of FoxA1 in prostate cancer metastasis.
Jin HJ; Zhao JC; Ogden I; Bergan RC; Yu J
Cancer Res; 2013 Jun; 73(12):3725-36. PubMed ID: 23539448
[TBL] [Abstract][Full Text] [Related]
9. The role of forkhead box A2 to restrict androgen-regulated gene expression of lipocalin 5 in the mouse epididymis.
Yu X; Suzuki K; Wang Y; Gupta A; Jin R; Orgebin-Crist MC; Matusik R
Mol Endocrinol; 2006 Oct; 20(10):2418-31. PubMed ID: 16740652
[TBL] [Abstract][Full Text] [Related]
10. The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesis.
Pomerantz MM; Li F; Takeda DY; Lenci R; Chonkar A; Chabot M; Cejas P; Vazquez F; Cook J; Shivdasani RA; Bowden M; Lis R; Hahn WC; Kantoff PW; Brown M; Loda M; Long HW; Freedman ML
Nat Genet; 2015 Nov; 47(11):1346-51. PubMed ID: 26457646
[TBL] [Abstract][Full Text] [Related]
11. Elevated levels of FOXA1 facilitate androgen receptor chromatin binding resulting in a CRPC-like phenotype.
Robinson JL; Hickey TE; Warren AY; Vowler SL; Carroll T; Lamb AD; Papoutsoglou N; Neal DE; Tilley WD; Carroll JS
Oncogene; 2014 Dec; 33(50):5666-74. PubMed ID: 24292680
[TBL] [Abstract][Full Text] [Related]
12. FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription.
Lupien M; Eeckhoute J; Meyer CA; Wang Q; Zhang Y; Li W; Carroll JS; Liu XS; Brown M
Cell; 2008 Mar; 132(6):958-70. PubMed ID: 18358809
[TBL] [Abstract][Full Text] [Related]
13. The mutational landscape of lethal castration-resistant prostate cancer.
Grasso CS; Wu YM; Robinson DR; Cao X; Dhanasekaran SM; Khan AP; Quist MJ; Jing X; Lonigro RJ; Brenner JC; Asangani IA; Ateeq B; Chun SY; Siddiqui J; Sam L; Anstett M; Mehra R; Prensner JR; Palanisamy N; Ryslik GA; Vandin F; Raphael BJ; Kunju LP; Rhodes DR; Pienta KJ; Chinnaiyan AM; Tomlins SA
Nature; 2012 Jul; 487(7406):239-43. PubMed ID: 22722839
[TBL] [Abstract][Full Text] [Related]
14. Cooperativity and equilibrium with FOXA1 define the androgen receptor transcriptional program.
Jin HJ; Zhao JC; Wu L; Kim J; Yu J
Nat Commun; 2014 May; 5():3972. PubMed ID: 24875621
[TBL] [Abstract][Full Text] [Related]
15. NFI transcription factors interact with FOXA1 to regulate prostate-specific gene expression.
Grabowska MM; Elliott AD; DeGraff DJ; Anderson PD; Anumanthan G; Yamashita H; Sun Q; Friedman DB; Hachey DL; Yu X; Sheehan JH; Ahn JM; Raj GV; Piston DW; Gronostajski RM; Matusik RJ
Mol Endocrinol; 2014 Jun; 28(6):949-64. PubMed ID: 24801505
[TBL] [Abstract][Full Text] [Related]
16. Mash1 expression is induced in neuroendocrine prostate cancer upon the loss of Foxa2.
Gupta A; Yu X; Case T; Paul M; Shen MM; Kaestner KH; Matusik RJ
Prostate; 2013 May; 73(6):582-9. PubMed ID: 23060003
[TBL] [Abstract][Full Text] [Related]
17. FOXA1 is a key determinant of estrogen receptor function and endocrine response.
Hurtado A; Holmes KA; Ross-Innes CS; Schmidt D; Carroll JS
Nat Genet; 2011 Jan; 43(1):27-33. PubMed ID: 21151129
[TBL] [Abstract][Full Text] [Related]
18. The Foxa family of transcription factors in development and metabolism.
Friedman JR; Kaestner KH
Cell Mol Life Sci; 2006 Oct; 63(19-20):2317-28. PubMed ID: 16909212
[TBL] [Abstract][Full Text] [Related]
19. FOXA1 and FOXA2: the regulatory mechanisms and therapeutic implications in cancer.
Liu N; Wang A; Xue M; Zhu X; Liu Y; Chen M
Cell Death Discov; 2024 Apr; 10(1):172. PubMed ID: 38605023
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
